NCT01578317View on ClinicalTrials.gov

Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

March 20, 2012

Primary Completion Date

January 31, 2016

Study Completion Date

January 31, 2016

Conditions
Influenza
Interventions
BIOLOGICAL

H5N1 vaccine plus AS03 adjuvant

H5N1 influenza vaccine with AS03 at the 3.75 mcg dose level given 21 days apart.

BIOLOGICAL

H5N1 vaccine without adjuvant

H5N1 influenza vaccine non- adjuvanted form at the 3.75 mcg dose level given 21 days apart.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT01578317 - Immune Responses to H5N1 Vaccine With and Without AS03 Adjuvant | Biotech Hunter | Biotech Hunter